COVID-19, coronavirus, repurposing approved drugs, engineering nanoparticles, virus infected cells, respiratory viral diseases, antioxidant, glutathione, T lymphocytes, immune modulating activity, anti-inflammatory response, antiviral effect, clinical translation Introduction The acute respiratory disease COVID-19 caused by the novel coronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has spawned a global pandemic with untold morbidity and mortality, accompanied by devastating disruption to all facets of society, economy, and health care system
Dimeric compounds are promising for simultaneously targeting dual binding domains, enhancing molecular recognition precision and consequently optimizing reaction dynamics and biochemical selectivity 13,14
2025;6:1001339 DOI: Received: January 16, 2025 Accepted: May 23, 2025 Published: June 23, 2025 Academic Editor: Undurti N
Epilepsia 49:9193
Semaglutide is a prescription medication that requires evaluation by a licensed healthcare provider
du Plessis, S